GenFleet Therapeutics (Shanghai) Inc.

Research GenFleet Therapeutics (Shanghai) Inc. (2595.HK) on Bullrun: market cap HKD 10.66B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker2595.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryBiotechnology
CurrencyHKD
Market capHKD 10.66B
Financial periodFY2025
RevenueCNY 130.27M
Revenue growth24.4%
Net income-CNY 1.79B
Free cash flow-CNY 135.81M
Gross margin64.2%

Valuation Snapshot

latest market cap is HKD 10.66B.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 130.27M	-CNY 1.79B	-CNY 135.81M	64.2%	-6.07	CNY 1.20B	CNY 100.92M	CNY 1.81B
FY2024	CNY 104.70M	-CNY 677.64M	-CNY 206.67M	80.8%	-2.16	CNY 362.13M	CNY 69.35M	-CNY 1.96B
FY2023	CNY 73.73M	-CNY 508.32M	-CNY 202.65M	99.1%	-1.62	CNY 332.20M	CNY 31.67M	-CNY 1.32B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 10.66B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About GenFleet Therapeutics (Shanghai) Inc.

GenFleet Therapeutics (Shanghai) Inc., a biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States. The company develops GFH375, an orally bioavailable small molecule inhibitor of Kirsten rat sarcoma (KRAS) G12C in a Phase III trial for the treatment of pancreatic cancer, as well as in Phase II trials for the treatment of non-small cell lung cancer (NSCLC) and BTC, and in a Phase I trial for the treatment of solid tumors;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Hualan Biological Engineering INC (002007.SZ) Shanghai RAAS Blood Products Co Ltd (002252.SZ) Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) CANbridge Pharmaceuticals Inc. (1228.HK) 3D Medicines Inc. (1244.HK) Ocumension Therapeutics (1477.HK) 3SBio Inc. (1530.HK) LongBio Pharma (Suzhou) Co., Ltd. (1779.HK) Innovent Biologics, Inc. (1801.HK) Viva Biotech Holdings (1873.HK) BioDlink International Company Limited (1875.HK)

Frequently asked questions

What is GenFleet Therapeutics (Shanghai) Inc.'s market cap?

GenFleet Therapeutics (Shanghai) Inc.'s market capitalization is HKD 10.66B.

What does GenFleet Therapeutics (Shanghai) Inc. do?

GenFleet Therapeutics (Shanghai) Inc., a biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States.